Deciphering gut microbiome 'chatter' to combat IBD

Inflammatory Bowel Disease (IBD) is a life-long, chronic condition characterized by sporadic bouts of gut inflammation causing debilitating symptoms. Crohn's Disease and Ulcerative Colitis -- the latter affecting around 1 in 400 people - are the two most common types of IBD. Current treatments are ineffective and seriously impact the quality of life of the patients and those of their families.